Last Updated: May 11, 2026

List of Excipients in API lamivudine and zidovudine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing lamivudine and zidovudine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Rebel Distributors Corp COMBIVIR lamivudine and zidovudine 21695-846 CELLULOSE, MICROCRYSTALLINE
Rebel Distributors Corp COMBIVIR lamivudine and zidovudine 21695-846 COLLOIDAL SILICON DIOXIDE
Rebel Distributors Corp COMBIVIR lamivudine and zidovudine 21695-846 HYPROMELLOSES
Rebel Distributors Corp COMBIVIR lamivudine and zidovudine 21695-846 MAGNESIUM STEARATE
Rebel Distributors Corp COMBIVIR lamivudine and zidovudine 21695-846 POLYETHYLENE GLYCOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing lamivudine and zidovudine

Company Ingredient NDC Excipient
Rebel Distributors Corp lamivudine and zidovudine 21695-996 CELLULOSE, MICROCRYSTALLINE
Rebel Distributors Corp lamivudine and zidovudine 21695-996 HYPROMELLOSE 2910
Rebel Distributors Corp lamivudine and zidovudine 21695-996 MAGNESIUM STEARATE
Rebel Distributors Corp lamivudine and zidovudine 21695-996 POLYETHYLENE GLYCOL 400
Rebel Distributors Corp lamivudine and zidovudine 21695-996 POLYSORBATE 80
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for lamivudine and zidovudine

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

lamivudine and zidovudine drug variants not containing COLLOIDAL SILICON DIOXIDE

Company Ingredient NDC
Rebel Distributors Corp lamivudine and zidovudine 21695-996
Camber Pharmaceuticals Inc lamivudine and zidovudine 31722-506
Camber Pharmaceuticals Inc lamivudine and zidovudine 31722-739
Macleods Pharmaceuticals Limited lamivudine and zidovudine 33342-003
PD-Rx Pharmaceuticals Inc lamivudine and zidovudine 43063-900
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

lamivudine and zidovudine drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Company Ingredient NDC
Rebel Distributors Corp lamivudine and zidovudine 21695-846
Rebel Distributors Corp lamivudine and zidovudine 21695-996
Camber Pharmaceuticals Inc lamivudine and zidovudine 31722-506
Camber Pharmaceuticals Inc lamivudine and zidovudine 31722-739
Macleods Pharmaceuticals Limited lamivudine and zidovudine 33342-003
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

lamivudine and zidovudine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Rebel Distributors Corp lamivudine and zidovudine 21695-846
Rebel Distributors Corp lamivudine and zidovudine 21695-996
Camber Pharmaceuticals Inc lamivudine and zidovudine 31722-506
Camber Pharmaceuticals Inc lamivudine and zidovudine 31722-739
Macleods Pharmaceuticals Limited lamivudine and zidovudine 33342-003
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links